Levocetirizine Dihydrochloride
CAS No. 130018-87-0
Levocetirizine Dihydrochloride( —— )
Catalog No. M33806 CAS No. 130018-87-0
Levocetirizine Dihydrochloride (Xyzal Dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Acting as an antihistaminic agent, it specifically targets the histamine H1-receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 41 | In Stock |
|
| 25MG | 72 | In Stock |
|
| 50MG | 122 | In Stock |
|
| 100MG | 178 | In Stock |
|
| 200MG | 267 | In Stock |
|
| 500MG | 462 | In Stock |
|
| 1G | 656 | In Stock |
|
Biological Information
-
Product NameLevocetirizine Dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevocetirizine Dihydrochloride (Xyzal Dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Acting as an antihistaminic agent, it specifically targets the histamine H1-receptor.
-
DescriptionLevocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria.
-
In Vitro——
-
In VivoLevocetirizine (0.4 mg/kg; oral administration; male Sprague-Dawley rats) treatment shows that the Cmax, AUC0-t , AUC0-∞ and t1/2 are 0.34 μg/mL, 3.26 μg h/mL, 3.67 μg h/mL and 2.34 hours, respectively in Sprague-Dawley rats.Animal Model:30 male Sprague-Dawley rats (8 weeks old; 200-250 g) Dosage:0.4 mg/kg Administration:Oral administration (Pharmacokinetic Analysis)Result:The Cmax, AUC0-t , AUC0-∞ and t1/2 were 0.34 μg/mL, 3.26 μg h/mL, 3.67 μg h/mL and 2.34 hours, respectively.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number130018-87-0
-
Formula Weight461.81
-
Molecular FormulaC21H27Cl3N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (216.54 mM; Ultrasonic )H2O : 100 mg/mL (216.54 mM; Ultrasonic)
-
SMILESO=C(O)COCCN1CCN([C@@H](C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lohar P, et al. Simultaneous bioanalysis and pharmacokinetic interaction study of acebrophylline, levocetirizine and pranlukast in Sprague-Dawley rats. Biomed Chromatogr. 2019 Dec;33(12):e4672.?
molnova catalog
related products
-
Ginsenoside Rb2
Ginsenoside Rb2 found in species of Panax, upregulating GPR120 gene expression.
-
Orphenadrine hydroch...
Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions, as well as the treatment of some aspects of Parkinson's disease.
-
Cetirizine
A second-generation antihistamine that acts as a selective H1 receptor antagonist; used in the treatment of allergies.AllergyApproved
Cart
sales@molnova.com